Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma
Joint Authors
Imad, M.
al-Ansari A.
al-Mulla N.
Falamarzi M.
Source
Issue
Vol. 20, Issue 2 (31 Dec. 2011), pp.41-43, 3 p.
Publisher
Publication Date
2011-12-31
Country of Publication
Qatar
No. of Pages
3
Main Subjects
Topics
Abstract EN
In our study we present two cases that have been diagnosed as stage I endometrial carcinoma where a Le-vonorgestrel intrauterine releasing system (LNG-IUS) referred to as Mirena was used as a primary treatment because the standard surgical treatment was deemed to carry an unacceptable risk of death.
Histopathology report after therapy showed complete regression of endometrial cancer.
American Psychological Association (APA)
al-Mulla N.& al-Ansari A.& Falamarzi M.& Imad, M.. 2011. Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Qatar Medical Journal،Vol. 20, no. 2, pp.41-43.
https://search.emarefa.net/detail/BIM-366551
Modern Language Association (MLA)
al-Mulla N.…[et al.]. Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Qatar Medical Journal Vol. 20, no. 2 (Dec. 2011), pp.41-43.
https://search.emarefa.net/detail/BIM-366551
American Medical Association (AMA)
al-Mulla N.& al-Ansari A.& Falamarzi M.& Imad, M.. Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Qatar Medical Journal. 2011. Vol. 20, no. 2, pp.41-43.
https://search.emarefa.net/detail/BIM-366551
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 43
Record ID
BIM-366551
